|
|
Previous Article | Table of Contents | Next Article 
Antibody-induced modulation and intracellular transport of CD10 and CD19
antigens in human B-cell lines: an immunofluorescence and immunoelectron
microscopy study
S Pulczynski, AM Boesen and OM Jensen
University Department of Pathology, Aarhus Amtssygehus, Denmark.
Antibody-induced antigenic modulation (AIAM) of CD10 and CD19 was studied
on NALM-6, RAJI, and JOK-1 cell lines using fluorescence microscopy (FM),
flow cytometry (FCM), and immunoelectron microscopy (IEM). Cross-linking
with monoclonal antibodies (MoAbs) induced rapid redistribution of CD10 and
CD19 on the cell surface (FM) followed by internalization involving uptake
through plasmalemmal pits, transfer through endosomal compartment
(receptor-mediated endocytosis), and, finally, delivery to lysosomes for
degradation or exocytosis and recycling (IEM). Significant quantitative
differences regarding modulation and intracellular processing were shown by
FCM and IEM. Thus, 35%, 30%, and 25% of CD10 compared with 80%, 60%, and
40% of CD19 were internalized in NALM-6, RAJI, and JOK-1 cells,
respectively. Also, the rate of intracellular transfer as well as
externalization and recycling was more pronounced in the case of CD19 than
of CD10 and in the NALM-6 and RAJI cells compared with the JOK-1 cells.
These differences may possibly reflect the functional significance of CD10
and CD19 as well as the stage of differentiation of the malignant B cells.
Although both antigens can be useful in MoAb-targeted immunotherapy, our
findings suggest that anti-CD19 MoAbs would be preferable for delivery of
cytotoxic agents to malignant B cells.
Volume 81,
Issue 6,
pp. 1549-1557,
03/15/1993
Copyright © 1993 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H.-P. Gerber, M. Kung-Sutherland, I. Stone, C. Morris-Tilden, J. Miyamoto, R. McCormick, S. C. Alley, N. Okeley, B. Hayes, F. J. Hernandez-Ilizaliturri, et al.
Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas
Blood,
April 30, 2009;
113(18):
4352 - 4361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fleischmann, T. Schlomm, H. Huland, J. Kollermann, P. Simon, M. Mirlacher, G. Salomon, F. H.K. Chun, T. Steuber, R. Simon, et al.
Distinct Subcellular Expression Patterns of Neutral Endopeptidase (CD10) in Prostate Cancer Predict Diverging Clinical Courses in Surgically Treated Patients
Clin. Cancer Res.,
December 1, 2008;
14(23):
7838 - 7842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Marks, M. S. Cooper, R. J. Anderson, K. H. Orchard, G. Hale, J. M. North, K. Ganeshaguru, A. J. Steele, A. B. Mehta, M. W. Lowdell, et al.
Selective Apoptotic Killing of Malignant Hemopoietic Cells by Antibody-Targeted Delivery of an Amphipathic Peptide
Cancer Res.,
March 15, 2005;
65(6):
2373 - 2377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Stel, B.-J. Kroesen, S. Jacobs, H. Groen, L. F. M. H. de Leij, H. C. Kluin-Nelemans, and S. Withoff
The Role of B Cell-Mediated T Cell Costimulation in the Efficacy of the T Cell Retargeting Bispecific Antibody BIS20x3
J. Immunol.,
November 15, 2004;
173(10):
6009 - 6016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Coffey, E. Stefanich, S. Palmieri, R. Eckert, J. Padilla-Eagar, P. J. Fielder, and S. Pippig
In Vitro Internalization, Intracellular Transport, and Clearance of an Anti-CD11a Antibody (Raptiva) by Human T-Cells
J. Pharmacol. Exp. Ther.,
September 1, 2004;
310(3):
896 - 904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Algeciras-Schimnich, L. Shen, B. C. Barnhart, A. E. Murmann, J. K. Burkhardt, and M. E. Peter
Molecular Ordering of the Initial Signaling Events of CD95
Mol. Cell. Biol.,
January 1, 2002;
22(1):
207 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-C. Goulet, V. S. Goldmacher, J. M. Lambert, C. Baron, D.-C. Roy, and E. Kouassi
Conjugation of Blocked Ricin to an Anti-CD19 Monoclonal Antibody Increases Antibody-Induced Cell Calcium Mobilization and CD19 Internalization
Blood,
September 15, 1997;
90(6):
2364 - 2375.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|